HW
TMO icon

Hedeker Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Hedeker Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.56M Sell
5,210
-255
-5% -$138K 0.54% 52
2025
Q4 		$3.17M Sell
5,465
-147
-3% -$83.1K 0.66% 45
2025
Q3 		$2.72M Sell
5,612
-233
-4% -$108K 0.57% 47
2025
Q2 		$2.37M Buy
5,845
+187
+3% +$78.2K 0.55% 51
2025
Q1 		$2.82M Sell
5,658
-1,876
-25% -$1.02M 0.76% 42
2024
Q4 		$3.92M Buy
7,534
+417
+6% +$229K 0.98% 36
2024
Q3 		$4.4M Buy
7,117
+221
+3% +$131K 1.17% 34
2024
Q2 		$3.81M Sell
6,896
-27
-0.4% -$15.5K 1.11% 36
2024
Q1 		$4.02M Sell
6,923
-692
-9% -$388K 1.16% 35
2023
Q4 		$4.04M Sell
7,615
-3,025
-28% -$1.46M 1.28% 30
2023
Q3 		$5.39M Buy
10,640
+4,084
+62% +$2.18M 1.87% 17
2023
Q2 		$3.42M Sell
6,556
-376
-5% -$203K 1.14% 33
2023
Q1 		$4M Buy
6,932
+146
+2% +$82.3K 1.42% 24
2022
Q4 		$3.74M Buy
6,786
+134
+2% +$71K 1.4% 24
2022
Q3 		$3.37M Buy
6,652
+2,328
+54% +$1.3M 1.31% 34
2022
Q2 		$2.42M Buy
+4,324
New +$2.38M 0.83% 42

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hedeker Wealth's TMO Position: Q1 2026 in Review

Hedeker Wealth reduced its Thermo Fisher Scientific (TMO) stake by 4.7% in Q1 2026, selling an estimated $138K and leaving 5,210 shares worth $2.56M. The position accounts for 0.54% of the portfolio, ranked #52.

Hedeker Wealth first reported a position in TMO in Q2 2022 and has held it in 16 quarters since. The position peaked at $5.39M in Q3 2023. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Hedeker Wealth held 5,210 shares of Thermo Fisher Scientific worth $2.56M as of Q1 2026.
  • Hedeker Wealth sold 255 Thermo Fisher Scientific shares in Q1 2026, an estimated $138K.
  • Thermo Fisher Scientific made up 0.54% of Hedeker Wealth's portfolio in Q1 2026, its #52 holding.
  • Hedeker Wealth first reported a position in Thermo Fisher Scientific in Q2 2022 and has held it in 16 quarters since.
  • Hedeker Wealth's Thermo Fisher Scientific position peaked at $5.39M in Q3 2023.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Hedeker Wealth's 13F filing for Q1 2026, filed 11 May 2026.